Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

NCT01109264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Bendamustine hydrochloride injection
DRUG: Chlorambucil

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.